Arcadia Biosciences, Inc. (RKDA) Return on equity 2017–2025
Arcadia Biosciences, Inc. (RKDA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-56.5%FY2025 · since FY2017: -196.2% → -56.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -56.5% | +56.6 pp |
| FY2024 | -113.1% | -4.2 pp |
| FY2023 | -108.9% | -35.8 pp |
| FY2022 | -73.1% | -26.0 pp |
| FY2021 | -47.1% | -30.4 pp |
| FY2020 | -16.8% | +357.1 pp |
| FY2019 | -373.8% | -268.7 pp |
| FY2018 | -105.2% | +91.0 pp |
| FY2017 | -196.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice